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Background: Cognitive event-related potential (P300) is an index of cognitive processing time. 
It was found to be prolonged in dementia, renal, and hepatic encephalopathies, but was not 
extensively assessed in respiratory failure.
Objective: To evaluate P300 changes in patients with respiratory failure, and especially those 
with mild or subclinical hypoxic–hypercapnic encephalopathy.
Methods: Auditory event-related evoked potential P300 latency was measured using an oddball 
paradigm in patients with respiratory failure due to any cause (partial pressure of oxygen in 
arterial blood (PO2) should be 75 mm/Hg or less). Apart from blood gases measurement, patients 
underwent the Mini-Mental State Examination (MMSE). Patient performances were compared 
with that of matched normal control. Patients were admitted into the study from outpatient clin-
ics and wards at King Khalid University Hospital and Sahara Hospital.
Results: Thirty-four patients (12 women, 22 men) were admitted to the study. Ages ranged 
from 19–67 years with a mean of 46.1 years. Respiratory failure was severe or very severe 
in 11 patients (33%), and mild or moderate in the rest (66%). Mean value for PO2 and partial 
pressure of carbon dioxide in arterial blood (PCO2) were 63.7 and 45.2 mm/Hg, respectively. 
pH mean was 7.4 and O2 saturation was 90.7%. P300 latency ranged from 218 to 393 milliseconds, 
with a mean of 338.4 milliseconds. In comparison with control (309.9 milliseconds), there 
was a significant difference (P = 0.007). P300 amplitude differences were not significant. No 
significant difference in MMSE was noted between mild and severe respiratory failure. Results 
of detailed neuropsychological assessment were clearly abnormal but were limited by the 
small number of tested patients. P300 latency changes correlated significantly with age as well 
as severity of respiratory failure. P300 was also significantly delayed whether hypoxia occurred 
with or without hypercapnia.
Conclusion: Results show a significant delay of P300 latency in patients with severe and mild 
respiratory failure. This was associated with subclinical encephalopathy in most patients, evi-
denced by a near-normal MMSE score. Apart from confirming the importance of P300 latency 
measurement as a marker of respiratory encephalopathy, this study asserts the causal relation-
ship between hypoxemia and cognitive derangement. Furthermore, it promotes the early use of 
oxygen therapy in a selected group of patients with mild or moderate respiratory failure, who 
have responsibilities which involve taking rapid critical decisions.
Keywords: event-related evoked potentials, hypoxic–hypercapnic encephalopathy, respiratory 
failure, chronic respiratory encephalopathy
Introduction
Chronic hypoxic–hypercapnic states occur in many pulmonary and cardiac diseases. 
These states affect the central nervous system causing well-described nonspecific clinical International Journal of COPD 2010:5 22
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manifestations including headache, dullness of mentation and 
drowsiness, confusion progressing in severe cases to coma with 
papilledema, asterixis, action tremor, and muscular twitching.1 
When these features appear in the context of a severe respi-
ratory failure, the association is clear, and electroencepha-
lography (EEG) shows marked slowing of brain activity.2,3 
On the other hand, mild chronic hypoxic conditions cause 
subtle or subclinical changes including inattention, reduc-
tion in psychomotor activity, forgetfulness, slight decrease 
of intelligence, slowing of reaction time, and abnormalities 
in constructional drawings.4–6 Grant and colleagues adminis-
tered the Halstead–Reitan neuropsychological test battery to 
patients with chronic obstructive pulmonary disease (COPD), 
and found their scores to be significantly lower than controls 
in all tests.5 COPD patient performance, particularly in tasks 
requiring sustained attention, was poor. In these instances, 
abnormalities of partial pressure of oxygen in arterial blood 
(PO2) and partial pressure of carbon dioxide in arterial blood 
(PCO2) can be easily confirmed by a simple blood test. On the 
contrary, there is no similar readily available objective tests 
for the assessment of associated cognitive derangement as 
structured neuropsychological tests are too complex and timely 
to be included in the clinical assessment of most patients. 
Heaton and Pendleton have strongly argued that many of these 
subtle cognitive impairment affects the quality of various daily 
activities.7 It is expected that such subtle cognitive dysfunction 
may have serious consequences in situations where patients 
are involved in activities requiring rapid critical decisions such 
as operators of complex machines.
Visual-, auditory-, and somatosensory-evoked potentials 
are well established neurophysiological tests and are widely 
used in investigating various neurological disorders.8–11 
Although its value in assessing acute hypoxic states is well 
established,12,13 its benefit in assessing the effect of chronic 
hypoxic–hypercapnic states on the nervous system was 
doubtful.14–19 Cognitive event-related evoked potentials 
(EREPs) are long-latency potentials obtained during infor-
mation processing tasks which involve attention, stimulus 
discrimination, memory, and related processes.20 Among 
the many EREP components, the P300 potential is the most 
widely studied and used. It is a positive-going potential with a 
modal latency of 300 ms and centroparietal scalp distribution, 
obtained usually by the oddball paradigm.21 P300 latency is an 
index of cognitive processing time and was shown to be pro-
longed in normal aging, confusional states, and dementia.22–24 
P300 latency has been found also to be a sensitive marker of sub-
clinical encephalopathy in hepatic and renal failure.25–28  The 
effect of acute hypoxia on EREP was studied in an experiment 
that utilized a simulated high altitude environment, and P300 
latency was found to be delayed.29 So far, few studies have 
described P300 latency abnormalities in chronic respiratory 
insufficiency.16,17,30 A group of 19 patients with mild or moder-
ate respiratory failure (RF) of different etiologies were studied 
by Barbieri and colleagues16 and another group of 17 patients 
with variable severity chronic RF by Nakano and colleagues.17 
Although their results show a tendency for P300 changes, these 
were not significant. Umahara and colleagues, on the other 
hand, in a selected group of 14 patients with post pulmonary 
tuberculosis RF, were able to detect a significant delay in P300.30 
Taking into account the large variability of P300 latency, these 
studies are limited by the relatively small number of studied 
subjects, besides the insignificant results in the first two. This 
study is designed to examine cognitive EREP in RF in a large 
group of patients and compare it with mental assessment 
results and measurement of blood gases. In particular, we aim 
to determine the sensitivity of P300 changes in detecting mild 
or subclinical cognitive impairment (ie, subclinical respiratory 
encephalopathy).
Patients and methods
Thirty-four patients, 12 females (35.3%) and 22 males (64.7%) 
were admitted to the study from both King Khalid University 
Hospital and Sahara Hospital out- and inpatient services. All 
had chronic RF with PCO2 of 75 mm/Hg or less, which could 
be either type I in the presence of hypoxia alone, or type II 
when combined with hypercapnia. All patients should be able 
to conduct all required assessments and investigations. Patients 
with any cause of mental dysfunction apart from RF were 
excluded. The severity of RF was defined according to PO2 
as mild (75–65 mm/Hg), moderate (64–60 mm/Hg), severe 
(59–50 mm/Hg), and very severe (50 mm/Hg). Patients 
underwent the following assessments and investigations:
Clinical:
(a)  Full neurological assessment
(b)  Mini-Mental State Examination (MMSE)
Arterial blood gases:
PO2, PCO2, PH, and O2 saturation.
Neurophysiological:
P300 in two-tone oddball paradigm (Figure 1).
Event-related potential recordings were performed using 
standard methods recommended by the International Federa-
tion of Clinical Neurophysiology (IFCN).31
Data analysis
The StatPac Gold (StatPac Inc., Bloomington, MN) statistical 
analysis package was utilized to analyze the results.International Journal of COPD 2010:5 23
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Results
Patient ages ranged from 19 to 67 years with a mean of 46.4 ± 
11.6 years. Eight were below the age of 40 years (25.8%), 
22 (61.3%) were aged 40–59 years, and four (12.9%) were 
older than 60 years. Biodata, P300 latency and amplitude, blood 
gases results, and MMSE scores are included in Table 1.
Thirty-six controls matched for age, sex, and education 
level were included. Their demographic data and results of 
P300 latency and amplitude measurements are included in 
Table 2.
Fourteen patients (40%) had severe or very severe RF, 
and 60% had mild to moderate severity RF.
The mean value for PO2 and PCO2 were 63.7 ± 14.3 mm/Hg 
(range from 32–90.7 mm/Hg), and 45.26 ± 10.68 mm/Hg 
(range from 30–79.8 mm/Hg) respectively. Mean value for 
pH was 7.4 ± 0.34 and 90.7% ± 7.2% for O2 saturation. 
MMSE scores ranged from 22–30 with a mean of 
26.1 ± 2.02. Table 3 summarizes these results. No significant 
difference in MMSE could be found between different 
subtypes of RF.
P300 (Cz) latencies in patients ranged from 268 to 393 ms, 
with a mean of 339.29 ± 54.26 ms. P300 amplitude was 
extremely variable at 13.52 ± 11.3 µv. The mean P300 latency 
in controls was 309.96 ± 29.15 ms, ranging from 220–372 ms, 
and P300 amplitude mean was 15.08 ± 6.43 µv. EREP results 
for patients and controls are summarized in Table 4.
P300 latency (Cz) was higher among patients than controls 
(339.29 ± 54.26 ms, vs 309.97 ± 27.08 ms), and was also 
higher for Pz measurements (339.06 ± 54.88 ms, vs 310.49 ± 
31.11 ms). The differences were statistically significant for 
both measurements (P = 0.005 and 0.008, respectively).
The mean P300 latency from all measurements was also 
significantly higher in patients than controls (338.44 ± 
53.99 ms vs 309.96 ± 29.15 ms; P = 0.007).
P300 amplitude at Cz and Pz were lower in patients 
than controls (16.68 ± 7.39 µv vs 13.52 ± 11.3 µv and 
13.48 ± 6.05 µv vs 11.41 ± 9.14 µv, respectively), but were 
not statistically significant. Also the mean P300 amplitude dif-
ference was not statistically significant (13.42 ± 12.2 µv vs 
15.08 ± 6.43 µv, respectively) between both groups. The 
mean P300 latency in patients changed from 324.2 ms in mild 
RF to 367.3 ms in very severe RF.
There is a moderate correlation between age and the mean 
P300 (latency) in cases (r = 0.54, P = 0.001), but not in controls 
Figure 1 P300 in two-tone oddball paradigm.International Journal of COPD 2010:5 24
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(r = 0.06, P = 0.71). The correlation between age and mean 
P300 amplitude was weak for cases and controls (r = 0.17, 
P = 0.32 and r = 0.07, P = 0.67, respectively).
Discussion
This study clearly confirm the occurrence of P300 latency 
delay in association with RF. This is consistent with results 
obtained by Umahara and colleagues in their selected group of 
14 patients with postpulmonary tuberculosis RF.30 P300 latency 
is already experimentally proven as marker of cognitive func-
tion (central processing time), and its delay has already been 
documented in other metabolic encephalopathies. Of special 
importance is the fact that significant P300 latency changes were 
observed in association with various degrees of RF, including 
the mild or subclinical states. Most patients with mild RF in this 
study had no or some nonspecific complaints, such as head-
ache, concentration, and memory difficulties, which usually do 
not raise significant clinical concern. Furthermore MMSE was 
Table 1 Biodata and results of blood gases, eReP, and MMse in 34 patients
Serial no File no Sex Age PO2 PCO2 PH O2  
Sat %
Fz Cz Pz  
Latency ms
Fz Cz Pz  
Amplitude µv
MMSE
1 466650 F 43 47.2 71.4 7.360 80.9 327 328 329 1.17 0.10 0.85 24
2 508904 M 53 39.7 35.3 7.464 78.2 326 332 344 10.40 8.05 7.11 25
3 596577 F 31 51.2 49.2 7.401 86.0 304 302 306 5.57 8.99 9.27 24
4 346571 M 62 75.2 44.5 7.400 95.0 359 358 358 9.27 8.93 11.00 23
5 596731 M 39 56.9 40.6 7.442 91.8 322 326 329 11.40 19.40 18.20 24
6 055464 M 45 32.0 64.2 7.353 63.2 332 332 332 4.97 4.36 6.69 26
7 543238 M 54 64.6 46.5 7.378 93.2 362 368 368 15.50 11.40 9.48 25
8 460117 M 53 47.2 49.7 7.362 84.2 392 393 397 52.80 20.80 11.60 24
9 416512 M 65 52.2 43.7 7.424 88.2 383 382 382 9.88 6.06 7.77 27
10 147927 M 67 49.6 52.2 7.379 83.6 549 558 554 20.30 12.10 7.36 28
11 414386 M 55 69.9 34.6 7.443 93.7 299 302 10.60 15.90 30
12 159095 M 30 52.1 49.3 7.378 84.1 304 283 282 16.20 13.50 7.71 27
13 206853 M 36 40.8 49.2 7.373 81.5 251 268 268 3.98 9.64 14.50 24
14 606009 M 46 62.5 40.6 7.450 92.5 294 295 306 7.89 15.60 12.80 27
15 611416 M 36 74.5 41.2 7.397 97.6 202 208 11.30 9.80 3.35 25
16 096204 M 57 65.5 43.1 7.398 93.0 352 352 352 23.60 18.30 14.90 29
17 111112 F 37 57.7 48.3 7.349 88.4 340 329 320 8.62 7.86 5.79 26
18 618472 F 50 54.0 65.5 7.398 86.8 368 372 367 9.23 16.70 10.80 25
19 612457 M 46 68.5 38.9 7.413 93.0 329 332 338 15.80 16.40 15.40 27
20 005619 F 40 67.4 39.8 7.431 96.6 311 308 312 15.60 20.40 17.00 28
21 345696 F 50 75.7 37.9 7.409 96.0 387 391 398 10.40 8.05 7.16 26
22 229859 M 38 57.9 39.5 7.423 92.6 378 374 374 4.99 9.01 10.40 25
23 055464 M 45 75.7 79.8 7.338 95.0 378 362 245 14.00 10.40 13.20 28
24 252915 M 38 58.5 47.1 7.407 90.3 351 332 331 6.59 3.10 2.54 24
25 344947 F 65 75.9 37.4 7.449 95.0 355 358 358 3.29 3.10 1.18 25
26 393969 F 50 75.2 44.0 7.394 96.8 336 336 338 18.10 16.70 17.40 26
27 535671 F 52 75.2 44.1 7.400 96.1 345 341 338 16.00 11.20 7.99 30
28 591569 M 19 73.7 38.2 7.374 94.5 309 308 305 8.05 16.40 20.60 27
29 596133 M 46 66.1 35.1 7.443 94.0 327 336 348 21.10 18.30 16.80 28
30 472146 M 58 72.8 30.9 7.463 95.5 330 334 334 101.60 68.50 53.60 29
31 568092 F 40 65.6 44.2 7.351 91.9 318 318 319 22.20 25.30 14.60 24
32 016557 F 58 70.3 40.7 7.396 94.1 311 312 312 0.73 6.76 10.10 22
33 514339 F 40 75.9 33.6 7.394 96.6 390 395 395 21.90 10.70 5.65 28
34 550413 M 26 64.8 38.7 7.421 93.0 319 309 309 6.49 7.86 3.59 27
Abbreviations: eReP, event-related evoked potentials; MMse, Mini-Mental state examination; PO2, partial pressure of oxygen in arterial blood; PCO2, partial pressure of 
carbon dioxide in arterial blood.International Journal of COPD 2010:5 25
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Table 3a summary of results blood gases and MMse in 34 patients with respiratory failure
Blood gas N = 34 Minimum Maximum Mean Median Standard deviation
PO2 32.0 90.7 63.72 65.15 14.34
PCO2 30.0 79.8 45.26 43.4 10.78
ph 7.34 7.46 7.4 7.4 0.34
O2 saturation 63.2 99.6 90.71 93.0 7.36
MMse 22.0 30.0 26.09 26.0 2.02
Abbreviations: MMse, Mini-Mental state examination; PO2, partial pressure of oxygen in arterial blood; PCO2, partial pressure of carbon dioxide in arterial blood.
Table 2 Biodata and results of P300 in 36 normal controls
Serial no Hospital no Age Sex Education/Work P300 Latency ms P300   Amplitude µv
1 111111 44 M College level 372 18.1
2 580776 41 F College level 313 13.2
3 068562 68 F College level 328 14.9
4 170476 57 F College level 356 19.3
5 155210 38 F College level 308 16.3
6 224721 57 F College level 309 28.2
7 382234 42 M College level 288 26.3
8 103774 49 F College level 334 20.0
9 050455 58 F College level 290 23.3
10 312645 55 M College level 220 14.5
11 149844 53 F College level 283 24.9
12 339360 45 F College level 361 11.0
13 123784 51 F College level 295 19.6
14 219041 56 F College level 344 5.83
15 469789 43 M secondary level 316 10.7
16 338830 50 F College level 258 10.3
17 344239 53 F College level 301 26.9
18 123456 54 F secondary level 305 21.1
19 041768 45 F secondary level 312 9.05
20 001020 63 M secondary level 333 16.2
21 015408 55 M secondary level 290 23.9
22 035526 62 M secondary level 306 10.1
23 002477 58 M secondary level 302 22.4
24 028034 48 M secondary level 274 5.98
25 070112 48 M secondary level 308 33.8
26 018549 57 M College level 309 7.06
27 396058 46 M College level 328 15.3
28 712658 62 M College level 355 22.8
29 851708 56 M College level 308 38.3
30 417765 55 M secondary level 301 13.1
31 123456 52 M secodary level 333 21.1
32 026199 50 M secondary level 338 8.9
33 123456 44 M College level 274 20.7
34 000440 47 M College level 319 15.1
35 000112 47 M College level 323 15.4
36 000000 40 F secondary level 308 13.1International Journal of COPD 2010:5 26
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Table 4 summary of results of eRePs in 34 patients with chronic 
respiratory failure and their controls
EREP Cases (X ± SD) Controls (X ± SD) t
Fz (latency) 339.29 ± 54.26 ms 309.97 ± 27.08 0.005*
Cz (latency) 339.06 ± 54.88 ms 310.49 ± 31.11 0.008*
Pz (latency) 338.06 ± 56.72 ms 309.43 ± 31.17 0.01*
Fz (amplitude) 15.28 ± 17.91 µv 15.08 ± 7.64 0.95
CZ (amplitude) 13.52 ± 11.30 µv 16.68 ± 7.39 0.165
PZ (amplitude) 11.41 ± 9.14 µv 13.48 ± 6.05 0.263
Mean P300 latency 338.44 ± 53.99 ms 309.96 ± 29.15 0.007*
Mean P300 amplitude 13.42 ± 12.9 µv 15.08 ± 6.43 0.471
Abbreviations: eReP, event-related evoked potentials; P300, cognitive event-related 
potential; sD, standard deviation.
Table 3b Data of neuropsychological findings in five patients who 
underwent a full battery of neuropsychological assessments
Test Mean Standard  
deviation
Assessment
Digit span (forward) 3.2 1.78 Very poor
Verbal immediate  
recall
8 2.9 Acceptable,  
but slightly low
Verbal delayed recall 6.4 2.6 Poor
Verbal fluency 26.1 1.64 good
Raven’s test 19.0 6.44 Poor
found to be insensitive in most of these patients. P300 latency 
may be of special importance in this group of patients that 
demonstrate the presence of definite, though subtle, cognitive 
derangement. This is because patients at this stage may be 
executing or undertaking complicated or risky tasks unaware 
that their mental performance is compromised. Misjudgments 
or miscalculated decisions may have serious consequences, 
increase the burden of stress, precipitate work and home 
difficulties, and possibly emotional disturbances, including 
depression. Different studies has been able to document subtle 
cognitive derangements in subclinical respiratory encepha-
lopathy using detailed neuropsychological assessments.4–6 In 
such patients, P300 measurement will be an objective method in 
assessing cognitive derangement and confirming the presence 
of ‘subclinical’ respiratory encephalopathy.
On another front, P300 derangement occurs in both 
types of RF, and Its latency correlated well with severity of 
hypoxemia in both types. In type 2 RF, it may be partially 
responsible, however, in type 1 it is the only culprit. The ques-
tion which arises here is whether correction of hypoxemia, 
however mild, may be of help in correcting the associated 
cognitive derangements. In cases of overt clinical respiratory 
encephalopathy associated with severe hypoxemia, the use of 
oxygen led to clear mental improvement, which formed the 
basis for portable oxygen therapy. Should portable oxygen 
be offered to patients with a milder degree of RF, especially 
those undertaking sophisticated, specialized professions? 
Results of the present study clearly goes in favor of such a 
decision, as the use of P300 latency as the marker of processing 
time was found to be prolonged in most of these patients. 
However a more definite answer to this question is expected 
from a prospective interventional study, where P300 latency 
is assessed before and after administering oxygen.
Finally, P300 latency varies widely in normal subjects, 
making measurements of individual patients of little use 
generally. Although we were able to establish a normal P300 
latency value with a two standard-error range in this study, 
the practical use of these absolute values in individual patients 
will require prolonged experience. The main benefit of this 
potential will be in assessing the benefit of a therapeutic 
modality, ie, oxygen, in a group of patients with respira-
tory encephalopathy. Or conversely, assessing the effect 
of any medicine used for other reasons on exacerbating 
encephalopathy. Taking into account the fact that all patients 
in the group of mild encephalopathy do not use oxygen 
therapy, it is reasonable to suggest that at least some of those 
patients may benefit from an earlier introduction of such 
treatment, especially a subgroup of patients holding critical 
responsibilities, in whom cognitive dysfunction may affect 
their optimum performance.
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